LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
LeMaitre (Nasdaq: LMAT) announced that its management will participate in investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre (Nasdaq: LMAT) announced that its management will participate in investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. The event will be held in a virtual format.
Details
News Market Reaction – LMAT
On Aug 7, the first trading day after this news, LMAT closed 0.78% above the previous close.
Data tracked by StockTitan Argus for the Aug 7 session.
Key Figures
- Conference edition
- 11th annual
- Needham Virtual MedTech & Diagnostics 1x1 Conference
- Investor meetings date
- August 11, 2026
- Needham Virtual MedTech & Diagnostics 1x1 Conference
Historical Context
-
Announced Q2 2026 results release date and conference call schedule
-
Announced participation in two June healthcare investor conferences
-
Scheduled management presentation at the Bank of America conference
-
Reported higher sales, margins, operating income, EPS, and cash balance
-
Announced Q1 2026 results release date and conference call schedule
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.